The Effect of Aromatase on the Reproductive Function of Obese Males

Abstract

Obesity has increased dramatically worldwide, which is associated with male infertility. Androgen deficiency, impaired spermatogenesis, and erectile dysfunction are characteristics of male infertility. The balance of androgens and estrogens is essential for maintaining normal reproductive function in males. Aromatase, the rate-limiting enzyme in the conversion of androgens into estrogens, is present in various tissues. The expression of aromatase is proportional to body fat mass and causes more fat accumulation, thus forming a vicious cycle. Excessive aromatase activity in adipose tissue leads to increased conversion of androgens into estrogens, eventually results in a reduction of testosterone levels and is the underlying reason for obesity-related infertility. In the male reproductive system, all testicular somatic cells and germ cells express aromatase, except for peritubular myoid cells. The results of studies regarding the effect of aromatase in testicular somatic cells and germ cells have been contradictory. The effect of estrogens in testicular somatic cells is inhibitory, leading to reduced testosterone levels and sperm production; however, it has been observed that aromatase participates in the acquisition of sperm motility. The overall effect of estrogen modulation is an inhibition of spermatogenesis. Aromatase inhibitors are an effective therapy for obesity-associated hypogonadism because they restore normal sex hormone levels and improve semen parameters. This article systematically introduces the basic knowledge of aromatase and provides information of the current advances relating to aromatase in male reproductive function. Increasing our knowledge on the role of aromatase in male obesity could help in proposing new approaches to treat infertile men.

Key words

aromatase - estrogens - obesity - reproduction - testosterone

• References

• 1 Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C. et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384: 766-781
• 2 Kelly T. YangW Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) 2008; 32: 1431-1437
• 3 Fui MN, Dupuis P, Grossmann M. Lowered testosterone in male obesity: Mechanisms, morbidity and management. Asian J Androl 2014; 16: 223-231
• 4 Stokes VJ, Anderson RA, George JT. How does obesity affect fertility in men – and what are the treatment options?. Clin Endocrinol (Oxf) 2015; 82: 633-638
• 5 Mah PM, Wittert GA. Obesity and testicular function. Mol Cell Endocrinol 2010; 316: 180-186
• 6 Zumoff B, Strain GW, Kream J, O’Connor J, Levin J, Fukushima DK. Obese young men have elevated plasma estrogen levels but obese premenopausal women do not. Metabolism 1981; 30: 1011-1014
• 7 Jensen TK, Andersson AM, Jorgensen N, Andersen AG, Carlsen E, Petersen JH, Skakkebaek NE. Body mass index in relation to semen quality and reproductive hormones among 1,558 Danish men. Fertil Steril 2004; 82: 863-870
• 8 Carreau S, Bois C, Zanatta L, Silva FR, Bouraima-Lelong H. DelalandeC. Estrogen signaling in testicular cells. Life Sci 2011; 89: 584-587
• 9 Carreau S, Bouraima-Lelong H, Delalande C. Estrogen, a female hormone involved in spermatogenesis. Adv Med Sci 2012; 57: 31-36
• 10 Carreau S, Delalande C, Galeraud-Denis I. Mammalian sperm quality and aromatase expression. Microsc Res Tech 2009; 72: 552-527
• 11 Carreau S, Bourguiba S, Lambard S, Galeraud-Denis I, Genissel C, Bilinska B, Benahmed M, Levallet J. Aromatase expression in male germ cells. J Steroid Biochem Mol Biol 2001; 79: 203-208
• 12 Lardone MC, Castillo P, Valdevenito R, Ebensperger M, Ronco AM, Pommer R, Piottante A, Castro A. P450-aromatase activity and expression in human testicular tissues with severe spermatogenic failure. Int J Androl 2010; 33: 650-660
• 13 Jones ME, Boon WC, McInnes K, Maffei L, Carani C, Simpson ER. Recognizing rare disorders: Aromatase deficiency. Nat Clin Pract Endocrinol Metab 2007; 3: 414-421
• 14 Cohen PG. Obesity in men: the hypogonadal-estrogen receptor relationship and its effect on glucose homeostasis. Med Hypotheses 2008; 70: 358-360
• 15 Harada N, Yamada K, Saito K, Kibe N, Dohmae S, Takagi Y. Structural characterization of the human estrogen synthetase (aromatase) gene. Biochem Biophys Res Commun 1990; 166: 365-372
• 16 Hanoux V, Bouraima H, Mittre H, Feral C, Benhaim A. Differential regulation of two 3′ end variants of P450 aromatase transcripts and of a new truncated aromatase protein in rabbit preovulatory granulosa cells. Endocrinology 2003; 144: 4790-4798
• 17 Sebastian S, Bulun SE. A highly complex organization of the regulatory region of the human CYP19 (aromatase) gene revealed by the Human Genome Project. J Clin Endocrinol Metab 2001; 86: 4600-4602
• 18 Czajka-Oraniec I, Simpson ER. Aromatase research and its clinical significance. Endokrynol Pol 2010; 61: 126-134
• 19 Rice S, Patel B, Bano G, Ugwumadu A, Whitehead SA. Aromatase expression in abdominal omental/visceral and subcutaneous fat depots: A comparison of pregnant and obese women. Fertil Steril 2012; 97: 1460-1466 e1
• 20 Coban N, Onat A, Guclu-Geyik F, Can G, Erginel-Unaltuna N. Sex- and Obesity-specific Association of Aromatase (CYP19A1) Gene Variant with Apolipoprotein B and Hypertension. Arch Med Res 2015; 46: 564-571
• 21 Meseguer A, Puche C, Cabero A. Sex steroid biosynthesis in white adipose tissue. Horm Metab Res 2002; 34: 731-736
• 22 Polari L, Yatkin E, Martinez Chacon MG, Ahotupa M, Smeds A, Strauss L, Zhang F, Poutanen M, Saarinen N, Makela SI. Weight gain and inflammation regulate aromatase expression in male adipose tissue, as evidenced by reporter gene activity. Mol Cell Endocrinol 2015; 412: 123-130
• 23 McInnes KJ, Brown KA, Knower KC, Chand AL, Clyne CD, Simpson ER. Characterisation of aromatase expression in the human adipocyte cell line SGBS. Breast Cancer Res Treat 2008; 112: 429-435
• 24 Simpson ER. Sources of estrogen and their importance. J Steroid Biochem Mol Biol 2003; 86: 225-230
• 25 Puche C, Jose M, Cabero A, Meseguer A. Expression and enzymatic activity of the P450c17 gene in human adipose tissue. Eur J Endocrinol 2002; 146: 223-229
• 26 Cohen PG. The hypogonadal-obesity cycle: Role of aromatase in modulating the testosterone-estradiol shunt–a major factor in the genesis of morbid obesity. Med Hypotheses 1999; 52: 49-51
• 27 Clyne CD, Speed CJ, Zhou J, Simpson ER. Liver receptor homologue-1 (LRH-1) regulates expression of aromatase in preadipocytes. J Biol Chem 2002; 277: 20591-20597
• 28 Simpson ER, Mendelson CR. Effect of aging and obesity on aromatase activity of human adipose cells. Am J Clin Nutr 1987; 45 (Suppl. 01) 290-295
• 29 Guerrero-Bosagna C, Savenkova M, Haque MM, Nilsson E, Skinner MK. Environmentally induced epigenetic transgenerational inheritance of altered Sertoli cell transcriptome and epigenome: Molecular etiology of male infertility. PLoS One 2013; 8: e59922
• 30 Silandre D, Delalande C, Durand P, Carreau S. Three promoters PII, PI.f, and PI.tr direct the expression of aromatase (cyp19) gene in male rat germ cells. J Mol Endocrinol 2007; 39: 169-181
• 31 Schulster M, Bernie AM, Ramasamy R. The role of estradiol in male reproductive function. Asian J Androl 2016; 18: 435-440
• 32 Gonzalez CR, Muscarsel Isla ML, Leopardo NP, Willis MA, Dorfman VB, Vitullo AD. Expression of androgen receptor, estrogen receptors alpha and beta and aromatase in the fetal, perinatal, prepubertal and adult testes of the South American plains Vizcacha, Lagostomus maximus (Mammalia, Rodentia). J Reprod Dev 2012; 58: 629-635
• 33 Nitta H, Bunick D, Hess RA, Janulis L, Newton SC, Millette CF, Osawa Y, Shizuta Y, Toda K, Bahr JM. Germ cells of the mouse testis express P450 aromatase. Endocrinology 1993; 132: 1396-1401
• 34 Balasinor NH, D’Souza R, Nanaware P, Idicula-Thomas S, Kedia-Mokashi N, He Z, Dym M. Effect of high intratesticular estrogen on global gene expression and testicular cell number in rats. Reprod Biol Endocrinol 2010; 8: 72
• 35 Carreau S, Bouraima-Lelong H, Delalande C. Estrogens: New players in spermatogenesis. Reprod Biol 2011; 11: 174-193
• 36 Carreau S, Silandre D, Bourguiba S, Hamden K, Said L, Lambard S, Galeraud-Denis I, Delalande C. Estrogens and male reproduction: A new concept. Braz J Med Biol Res 2007; 40: 761-768
• 37 Janulis L, Hess RA, Bunick D, Nitta H, Janssen S, Asawa Y, Bahr JM. Mouse epididymal sperm contain active P450 aromatase which decreases as sperm traverse the epididymis. J Androl 1996; 17: 111-116
• 38 Levallet J, Bilinska B, Mittre H, Genissel C, Fresnel J, Carreau S. Expression and immunolocalization of functional cytochrome P450 aromatase in mature rat testicular cells. Biol Reprod 1998; 58: 919-926
• 39 Armamento-Villareal R, Aguirre LE, Qualls C, Villareal DT. Effect of Lifestyle Intervention on the Hormonal Profile of Frail Obese Older Men. J Nutr Health Aging 2016; 20: 334-340
• 40 Belanger C, Luu-The V, Dupont P, Tchernof A. Adipose tissue intracrinology: Potential importance of local androgen/estrogen metabolism in the regulation of adiposity. Horm Metab Res 2002; 34: 737-745
• 41 Wake DJ, Strand M, Rask E, Westerbacka J, Livingstone DE, Soderberg S, Andrew R, Yki-Jarvinen H, Olsson T, Walker BR. Intra-adipose sex steroid metabolism and body fat distribution in idiopathic human obesity. Clin Endocrinol (Oxf) 2007; 66: 440-446
• 42 Williams GP. The role of oestrogen in the pathogenesis of obesity, type 2 diabetes, breast cancer and prostate disease. Eur J Cancer Prev 2010; 19: 256-271
• 43 Vermeulen A, Kaufman JM, Goemaere S, van Pottelberg I. Estradiol in elderly men. Aging Male 2002; 5: 98-102
• 44 Williams G. Aromatase up-regulation, insulin and raised intracellular oestrogens in men, induce adiposity, metabolic syndrome and prostate disease, via aberrant ER-alpha and GPER signalling. Mol Cell Endocrinol 2012; 351: 269-278
• 45 Schulte DM, Hahn M, Oberhauser F, Malchau G, Schubert M, Heppner C, Muller N, Gudelhofer H, Faust M, Krone W, Laudes M. Caloric restriction increases serum testosterone concentrations in obese male subjects by two distinct mechanisms. Horm Metab Res 2014; 46: 283-286
• 46 Kloner RA, Carson 3rd C, Dobs A, Kopecky S, Mohler 3rd ER. Testosterone and Cardiovascular Disease. J Am Coll Cardiol 2016; 67: 545-557
• 47 Sinclair M, Grossmann M, Gow PJ, Angus PW. Testosterone in men with advanced liver disease: Abnormalities and implications. J Gastroenterol Hepatol 2015; 30: 244-251
• 48 Helo S, Ellen J, Mechlin C, Feustel P, Grossman M, Ditkoff E, McCullough A. A randomized prospective double-blind comparison trial of clomiphene citrate and anastrozole in raising testosterone in hypogonadal infertile men. J Sex Med 2015; 12: 1761-1769
• 49 Pintana H, Chattipakorn N, Chattipakorn S. Testosterone deficiency, insulin-resistant obesity and cognitive function. Metab Brain Dis 2015; 30: 853-876
• 50 Stephens SM, Polotsky AJ. Big enough for an aromatase inhibitor? How adiposity affects male fertility. Semin Reprod Med 2013; 31: 251-257
• 51 Deutschbein T, Mann K, Petersenn S. Total testosterone and calculated estimates for free and bioavailable testosterone: influence of age and body mass index and establishment of sex-specific reference ranges. Horm Metab Res 2015; 47: 846-854
• 52 Abate N, Haffner SM, Garg A, Peshock RM, Grundy SM. Sex steroid hormones, upper body obesity, and insulin resistance. J Clin Endocrinol Metab 2002; 87: 4522-4527
• 53 Colangelo LA, Ouyang P, Liu K, Kopp P, Golden SH, Dobs AS, Szklo M, Vaidya D, Cushman M, Gapstur SM. Association of endogenous sex hormones with diabetes and impaired fasting glucose in men: multi-ethnic study of atherosclerosis. Diabetes Care 2009; 32: 1049-1051
• 54 Hammoud A, Carrell DT, Meikle AW, Xin Y, Hunt SC, Adams TD, Gibson M. An aromatase polymorphism modulates the relationship between weight and estradiol levels in obese men. Fertil Steril 2010; 94: 1734-1738
• 55 Roth MY, Amory JK, Page ST. Treatment of male infertility secondary to morbid obesity. Nat Clin Pract Endocrinol Metab 2008; 4: 415-419
• 56 Hofstra J, Loves S, van Wageningen B, Ruinemans-Koerts J, Jansen L, de Boer H. High prevalence of hypogonadotropic hypogonadism in men referred for obesity treatment. Neth J Med 2008; 66: 103-109
• 57 Lee HK, Lee JK, Cho B. The role of androgen in the adipose tissue of males. World J Mens Health 2013; 31: 136-140
• 58 Loves S, Ruinemans-Koerts J, de Boer H. Letrozole once a week normalizes serum testosterone in obesity-related male hypogonadism. Eur J Endocrinol 2008; 158: 741-747
• 59 Bekaert M, Van Nieuwenhove Y, Calders P, Cuvelier CA, Batens AH, Kaufman JM, Ouwens DM, Ruige JB. Determinants of testosterone levels in human male obesity. Endocrine 2015; 50: 202-211
• 60 Strain GW, Zumoff B, Kream J, Strain JJ, Deucher R, Rosenfeld RS, Levin J, Fukushima DK. Mild Hypogonadotropic hypogonadism in obese men. Metabolism 1982; 31: 871-875
• 61 Ding C, Guo J, Su Z. The status of research into resistance to diet-induced obesity. Horm Metab Res 2015; 47: 404-410
• 62 Rosati L, Agnese M, Di Fiore MM, Andreuccetti P, Prisco M. P450 aromatase: a key enzyme in the spermatogenesis of the Italian wall lizard, Podarcis sicula. J Exp Biol 2016; 219 (Pt 15) 2402-2408
• 63 Carreau S, Hess RA. Oestrogens and spermatogenesis. Philos Trans R Soc Lond B Biol Sci 2010; 365: 1517-1535
• 64 O’Donnell L, Robertson KM, Jones ME, Simpson ER. Estrogen and spermatogenesis. Endocr Rev 2001; 22: 289-318
• 65 Dimitriadis F, Tsiampali C, Chaliasos N, Tsounapi P, Takenaka A, Sofikitis N. The Sertoli cell as the orchestra conductor of spermatogenesis: Spermatogenic cells dance to the tune of testosterone. Hormones (Athens) 2015; 14: 479-503
• 66 Genissel C, Levallet J, Carreau S. Regulation of cytochrome P450 aromatase gene expression in adult rat Leydig cells: Comparison with estradiol production. J Endocrinol 2001; 168: 95-105
• 67 Boitani C, Ritzen EM, Parvinen M. Inhibition of rat Sertoli cell aromatase by factor(s) secreted specifically at spermatogenic stages VII and VIII. Mol Cell Endocrinol 1981; 23: 11-22
• 68 Bourguiba S, Genissel C, Lambard S, Bouraima H, Carreau S. Regulation of aromatase gene expression in Leydig cells and germ cells. J Steroid Biochem Mol Biol 2003; 86: 335-343
• 69 Quignot N, Desmots S, Barouki R, Lemazurier E. A comparison of two human cell lines and two rat gonadal cell primary cultures as in vitro screening tools for aromatase modulation. Toxicol In Vitro 2012; 26: 107-118
• 70 Chen SR, Tang JX, Cheng JM, Li J, Jin C, Li XY, Deng XL, Zhang Y, Wang XX, Liu YX. Loss of Gata4 in Sertoli cells impairs the spermatogonial stem cell niche and causes germ cell exhaustion by attenuating chemokine signaling. Oncotarget 2015; 6: 37012-37027
• 71 Aquila S, Sisci D, Gentile M, Middea E, Catalano S, Carpino A, Rago V, Ando S. Estrogen receptor (ER)alpha and ER beta are both expressed in human ejaculated spermatozoa: Evidence of their direct interaction with phosphatidylinositol-3-OH kinase/Akt pathway. J Clin Endocrinol Metab 2004; 89: 1443-1451
• 72 Rochira V, Granata AR, Madeo B, Zirilli L, Rossi G, Carani C. Estrogens in males: What have we learned in the last 10 years?. Asian J Androl 2005; 7: 3-20
• 73 Carreau S, de Vienne C, Galeraud-Denis I. Aromatase and estrogens in man reproduction: A review and latest advances. Adv Med Sci 2008; 53: 139-144
• 74 Carreau S, Wolczynski S, Galeraud-Denis I. Aromatase, oestrogens and human male reproduction. Philos Trans R Soc Lond B Biol Sci 2010; 365: 1571-1579
• 75 Carreau S, Bouraima-Lelong H, Delalande C. Estrogens in male germ cells. Spermatogenesis 2011; 1: 90-94
• 76 Aquila S, Sisci D, Gentile M, Carpino A, Middea E, Catalano S, Rago V, Ando S. Towards a physiological role for cytochrome P450 aromatase in ejaculated human sperm. Hum Reprod 2003; 18: 1650-1659
• 77 Hammoud AO, Gibson M, Peterson CM, Hamilton BD, Carrell DT. Obesity and male reproductive potential. J Androl 2006; 27: 619-626
• 78 Raman JD, Schlegel PN. Aromatase inhibitors for male infertility. J Urol 2002; 167 (2 Pt 1) 624-629
• 79 Schlegel PN. Aromatase inhibitors for male infertility. Fertil Steril 2012; 98: 1359-1362
• 80 Rambhatla A, Mills JN, Rajfer J. The Role of Estrogen Modulators in Male Hypogonadism and Infertility. Rev Urol 2016; 18: 66-72
• 81 Cabler S, Agarwal A, Flint M, du Plessis SS. Obesity: Modern man’s fertility nemesis. Asian J Androl 2010; 12: 480-489
• 82 de Boer H, Verschoor L, Ruinemans-Koerts J, Jansen M. Letrozole normalizes serum testosterone in severely obese men with hypogonadotropic hypogonadism. Diabetes Obes Metab 2005; 7: 211-215
• 83 Zumoff B, Miller LK, Strain GW. Reversal of the hypogonadotropic hypogonadism of obese men by administration of the aromatase inhibitor testolactone. Metabolism 2003; 52: 1126-1128
• 84 Pavlovich CP, King P, Goldstein M, Schlegel PN. Evidence of a treatable endocrinopathy in infertile men. J Urol 2001; 165: 837-841
• 85 Loves S, de Jong J, van Sorge A, Telting D, Tack CJ, Hermus A, Westerterp K, de Boer H. Somatic and psychological effects of low-dose aromatase inhibition in men with obesity-related hypogonadotropic hypotestosteronemia. Eur J Endocrinol 2013; 169: 705-714
• 86 Saylam B, Efesoy O, Cayan S. The effect of aromatase inhibitor letrozole on body mass index, serum hormones, and sperm parameters in infertile men. Fertil Steril 2011; 95: 809-811
• 87 Aydogdu A, Swerdloff RS. Emerging medication for the treatment of male hypogonadism. Expert Opin Emerg Drugs 2016; 21: 255-266
• 88 Kotula-Balak M, Bablok L, Fracki S, Jankowska A, Bilinska B. Immunoexpression of androgen receptors and aromatase in testes of patient with Klinefelter’s syndrome. Folia Histochem Cytobiol 2004; 42: 215-220
• 89 Bernardino RL, Alves MG, Silva J, Barros A, Ferraz L, Sousa M, Sa R, Oliveira PF. Expression of Estrogen Receptors Alpha (ER-alpha), Beta (ER-beta), and G Protein-Coupled Receptor 30 (GPR30) in Testicular Tissue of Men with Klinefelter Syndrome. Horm Metab Res 2016; 48: 413-415
• 90 Wosnitzer MS, Paduch DA. Endocrinological issues and hormonal manipulation in children and men with Klinefelter syndrome. Am J Med Genet C Semin Med Genet 2013; 163C: 16-26
• 91 Shozu M, Sebastian S, Takayama K, Hsu WT, Schultz RA, Neely K, Bryant M, Bulun SE. Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene. N Engl J Med 2003; 348: 1855-1865
• 92 Lardone MC, Argandona F, Florez M, Parada-Bustamante A, Ebensperger M, Palma C, Piottante A, Castro A. Overexpression of CYP19A1 aromatase in Leydig cells is associated with steroidogenic dysfunction in subjects with Sertoli cell-only syndrome. Andrology 2017; 5: 41-48
• 93 Panza S, Malivindi R, Chemi F, Rago V, Giordano C, Barone I, Bonofiglio D, Gelsomino L, Giordano F, Ando S, Catalano S. Glucocorticoid receptor as a potential target to decrease aromatase expression and inhibit leydig tumor growth. Am J Pathol 2016; 186: 1328-1339
• 94 Li X, Strauss L, Kaatrasalo A, Mayerhofer A, Huhtaniemi I, Santti R, Makela S, Poutanen M. Transgenic mice expressing p450 aromatase as a model for male infertility associated with chronic inflammation in the testis. Endocrinology 2006; 147: 1271-1277